14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:JUNO
Delisted

Juno Therapeutics Fund Predictions

$86.96
+0 (+0%)
At Close: Mar 28, 2018
Currently predicting for Tue, 7 May 2024

Trading levels for JUNO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 86.96 .
R2 86.96 .
R1 86.96 .
Current price: 86.96
Support S1 86.96 .
S2 86.96 .
S3 86.96 .

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 86.96
Support S1 86.64 -0.368%
S2 86.00 -1.10%
S3 69.25 -20.37%

JUNO Predictions History

6 years ago
JuanC Villegas predicted that JUNO for 2017-11-06 is going $56.16 (-0.51%)

6 years ago
JS predicted that JUNO for 2017-11-06 is going $55.95 (-0.89%)

6 years ago
JuanC Villegas predicted that JUNO for 2017-09-13 is going $42.22 (0.17%)

6 years ago
JS predicted that JUNO for 2017-09-08 is going $43.22 (3.27%)

6 years ago
JuanC Villegas predicted that JUNO for 2017-09-08 is going $43.42 (1.90%)

7 years ago
Stockdum predicted that JUNO for 2016-05-18 is going $38.51 (0.44%)

Click to get the best stock tips daily for free!

About Juno Therapeutics

Juno Therapeutics, Inc., a biopharmaceutical company, engages in developing cell-based cancer immunotherapies. The company develops cell-based cancer immunotherapies based on its chimeric antigen receptor and T cell receptor technologies to genetically engineer T cells to recognize and kill cancer cells. Its clinical stage CD19 product candidates include JCAR015 that is in Phase II clinical trials for adult patients with relapsed/refractory B cel... JUNO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT